Illness	Number of cases
Heart failure (I50.01)	334
Pneumonia organism unspecified - Pneumonia unspecified organism (J18.9)	190
Essential primary hypertension (I10.01)	151
Atrial fibrillation and flutter - Paroxysmal atrial fibrillation (I48.0)	149
Syncope and collapse (R55)	127
Essential primary hypertension (I10.91)	110
Left ventricular failure unspecified (I50.14)	90
Chronic obstructive pulmonary disease with acute lower respiratory infection (J44.09)	83
Pneumonitis due to solids and liquids - Pneumonitis due to inhalation of food and vomit (J69.0)	69
Left ventricular failure unspecified (I50.13)	49

Top 10 treatments

Treatment	Number
(9-984.7)	518
Others therapeutic procedures to influence the immune system (8-547.31)	353
(9-984.8)	310
Measurement of lung function in an airtight cabin - whole body plethysmography (1-710)	300
Treatment procedure to maintain and encourage practical everyday and social skills - psychosocial intervention (9-401.22)	284
Others therapeutic procedures to influence the immune system (8-547.30)	275
Treatment by specific positioning of the patient in bed, e.g. positioning in a sling table or special bed (8-390.x)	212
Examination of the bronchi by taking a sample of fluid or tissue with a needle (1-843)	206
Analysis of the amount of carbon monoxide taken in and given off by the lungs (1-711)	190
Measurement of the air remaining in the lungs after normal expiration, using the helium dilution method (1-713)	190

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0108

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

External quality assurance according to the DMP

Koronare Herzkrankheit (KHK)

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
54	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
37	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
24	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Participation in multi-centre Phase I/II studies
Project-related cooperation with colleges and universities
Lectureships / teaching posts at colleges and universities
Student training (clinical traineeship / internship year)
Participation in multi-centre phase III/IV studies	Chirurgie colo-rektaler Carzinome

Training

No.	Training in other healing professions	Comment
HB13	Medical technical assistant for functional diagnostics (MTAF) (m/f)	Konzerneigene Ausbildungsakademie
HB01	Nurse and health care worker (m/f)
HB03	Physical therapist / physiotherapist (m/f)
HB07	Surgical technical assistant (m/f)